An assessment of dose accuracy and injection force of a novel prefilled insulin pen: Comparison with a widely used prefilled insulin pen

Expert Opinion on Drug Delivery

Volumn 8, Issue 10, 2011, Pages 1271-1276

  Wielandt, Jakob O ^a   Niemeyer, Marcus ^a   Hansen, Marianne R ^a   Bucher, Ditlef ^a   Thomsen, Niels B ^a  

^a NOVO NORDISK A S   (Denmark)

Author keywords

Accuracy; Diabetes; Injection force; Insulin pen

Indexed keywords

INSULIN ASPART; INSULIN DETEMIR;

ARTICLE; DENMARK; DIABETES MELLITUS; DRUG MEGADOSE; HUMAN; INJECTION; LOW DRUG DOSE; OUTCOME ASSESSMENT; TREATMENT OUTCOME;

HUMANS; INJECTIONS; INSULIN; MEDICATION ERRORS; SYRINGES;

EID: 80053069947     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2011.615308     Document Type: Article

References (27)

1. Hamilton JG. Needle phobia: a neglected diagnosis. J Fam Pract 1995;41:169-75
2. Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance. Diabetes Care 1997;20:292-8 (Pubitemid 27098212)
3. Korytkowski M, Niskanen L, Asakura T. FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther 2005;27(Suppl B):S89-100
4. Mollema ED, Snoek FJ, Ader HJ, et al. Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: psychological comorbidity and general well-being. J Psychosom Res 2001;51:665-72 (Pubitemid 34007445)
5. Mollema ED, Snoek FJ, Heine RJ, et al. Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening. Diabet Med 2001;18:671-4 (Pubitemid 32823067)
6. Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 2004;43:69-74 (Pubitemid 38112268)
7. Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 1999;22:137-40 (Pubitemid 29028310)
8. Graff MR, McClanahan MA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther 1998;20:486-96 (Pubitemid 28343501)
9. Lee WC, Balu S, Cobden D, et al. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006;28:1712-25; discussion 0-1 (Pubitemid 44841979)
10. Lombardo F, Salzano G, Messina MF, et al. Compliance and administration methods in management of type 1 diabetes. Acta Biomed 2005;76(Suppl 3):66-9 (Pubitemid 351767168)
11. Baser O, Bouchard J, DeLuzio T, et al. Assessment of adherence and healthcare costs of insulin device (FlexPen) versus conventional vial/syringe. Adv Ther 2010;27:94-104
12. Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495-7 (Pubitemid 39281409)
13. Asakura T, Seino H, Kageyama M, et al. Dosing accuracy of two insulin pre-filled pens. Curr Med Res Opin 2008;24:1429-34 (Pubitemid 351741576)
14. Hanel H, Weise A, Sun W, et al. Differences in the dose accuracy of insulin pens. J Diabetes Sci Tech 2008;2:478-81
15. Pfutzner A, Reimer T, Frokjaer LPF, et al. Prefilled insulin device with reduced injection force: patient perception and accuracy. Curr Med Res Opin 2008;24:2545-9
16. Weise A, Pfutzner JW, Borig J, et al. Comparison of the dose accuracy of prefilled insulin pens. J Diabetes Sci Tech 2009;3:149-53
17. Asakura T, Seino H, Kageyama M, et al. Evaluation of injection force of three insulin delivery pens. Expert Opin Pharmacother 2009;10:1389-93
18. Rissler J, Jorgensen C, Rye Hansen M, et al. Evaluation of injection force dynamics of a modified prefilled insulin pen. Expert Opin Pharmacother 2008;9:2217-22
19. Frey MI, Barrett-Connor E, Sledge PA, et al. The effect of noninsulin dependent diabetes mellitus on the prevalence of clinical osteoarthritis. A population based study. J Rheumatol 1996;23:716-22
20. Savas S, Koroglu BK, Koyuncuoglu HR, et al. The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients. Diabetes Res Clin Pract 2007;77:77-83 (Pubitemid 46590476)
21. Schady W, Abuaisha B, Boulton AJ. Observations on severe ulnar neuropathy in diabetes. J Diabetes Complications 1998;12:128-32 (Pubitemid 28241436)
22. Starkman HS, Gleason RE, Rand LI, et al. Limited joint mobility (LJM) of the hand in patients with diabetes mellitus: relation to chronic complications. Ann Rheum Dis 1986;45:130-5 (Pubitemid 16162480)
23. Ziegler D, Gries FA, Spuler M, et al. The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabetes Med 1993;10(Suppl 2):82S-6S (Pubitemid 23162713)
24. Hemmingsen H, Niemeyer M, Hansen MR, et al. A prefilled insulin pen with a novel injection mechanism and a lower injection force than other prefilled insulin pens. Diabetes Technol Ther 2011;13:10.1089/dia.2011.0110
25. Wielandt JO, Niemeyer M, Hansen MR, et al. FlexTouch: a prefilled insulin pen with a novel injection mechanism with consistent high accuracy at low-(1IU), medium-(40IU) and high-80(IU) dose settings. J Diabetes Sci Technol 2011; In press
26. Asakura T. Comparison of the dosing accuracy of two insulin injection devices. J Clin Res 2005;8:33-40 (Pubitemid 43041653)
27. Bohannon NJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med 1999;106:57-8; 61-4, 8